[Federal Register: August 13, 1999 (Volume 64, Number 156)]
[Notices]               
[Page 44226-44227]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13au99-85]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 99N-1075]

 
Public Health Impact of Vibrio Parahaemolyticus in Molluscan 
Shellfish

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA), Center for Food Safety 
and Applied Nutrition, in conjunction with the National Advisory 
Committee on Microbiological Criteria for Foods, in cooperation with 
the Food Safety and Inspection Service, U.S. Department of Agriculture 
(FSIS/USDA) is announcing a public meeting to discuss issues related to 
a preliminary risk assessment model examining the relationship between 
Vibrio parahaemolyticus and human health.

DATES: The public meeting will be held on Friday, September 24, 1999, 
from 8 a.m. to 3:15 p.m. Submit registration and written notices of 
participation by September 13, 1999. Submit written comments by October 
25, 1999.

ADDRESSES: The public meeting will be held at The Washington Plaza 
Hotel, 10 Thomas Circle, NW., at Massachusetts Ave. and 14th St., 
Washington, DC. Submit registration and written notices of 
participation to Catherine M. DeRoever (address below). Submit written 
comments to the Dockets Management Branch (HFA-305), Food an Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Two 
copies of any comments are to be submitted, except that individuals may 
submit one copy. Comments are to be identified with the docket number 
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Catherine M. DeRoever, Advisory 
Committee Office (HFS-22), Center for Food Safety and Applied 
Nutrition, Food and Drug Administration, 200 C St. SW., Washington, DC 
20204, 202-205-4251, FAX 202-205-4970, or e-mail 
``cderoeve@bangate.fda.gov''.
    Those persons interested in attending the public meeting should, by 
September 13, 1999, fax their name, title, firm name, address, and 
telephone number to Catherine M. DeRoever (fax number above).
    Those persons interested in presenting information at the public 
meeting should, by September 13, 1999, fax their name, title, firm 
name, address, telephone number, and an outline of their presentation 
to Catherine M. DeRoever (fax number above).
    There is no registration fee for this public meeting, but advance 
registration is suggested. Interested persons are encouraged to 
register early because space may be limited.

SUPPLEMENTARY INFORMATION: This public meeting will provide an 
opportunity for review and comment of the preliminary V. 
parahaemolyticus risk assessment. The role of factors in the 
environment, post harvest handling and processing in the probability of 
illness will be described. Integration of epidemiology, consumption, 
and dose-response will be modeled. Scientific inferences, assumptions, 
and modeling tools will be made from the completed search of peer 
reviewed literature. Comments will be requested on the approaches and 
analyses presented and any additional information that should be 
included in the analyses.
    The sponsoring agencies encourage individuals with relevant 
scientific data or information to present such information at the 
meeting or in written comments to this record.
    A transcript of the public meeting will be prepared. Copies of the 
transcript may be requested in writing from the Freedom of Information 
Office (HFI-35), Food and Drug Administration, 5600 Fishers Lane, rm. 
12A-16, Rockville, MD 20857, approximately 15 working days after the 
meeting. The transcript of the public meeting and submitted comments 
will be available for public examination at the Dockets Management 
Branch (address above) between 9 a.m. and 4 p.m., Monday through 
Friday.


[[Page 44227]]


    Dated: August 6, 1999.
 Margaret M. Dotzel,
 Acting Associate Commissioner for Policy.
[FR Doc. 99-20991 Filed 8-12-99; 8:45 am]
BILLING CODE 4160-01-F